Results 51 to 60 of about 173,987 (367)

Foregut microbiome in development of esophageal adenocarcinoma [PDF]

open access: yes, 2010
Esophageal adenocarcinoma (EA), the type of cancer linked to heartburn due to gastroesophageal reflux diseases (GERD), has increased six fold in the past 30 years. This cannot currently be explained by the usual environmental or by host genetic factors.
Aaron Tenney   +27 more
core   +2 more sources

WHAT IS THE REAL IMPAIRMENT ON ESOPHAGEAL MOTILITY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE?

open access: yesArquivos de Gastroenterologia, 2013
Context Impairment of esophageal motility is a common finding in patients with gastroesophageal reflux disease (GERD) as reduced lower esophageal sphincter (LES) basal pressure.
Angela FALCÃO   +4 more
doaj   +1 more source

The Effect of Abdominal Visceral Fat, Circulating Inflammatory Cytokines, and Leptin Levels on Reflux Esophagitis

open access: yesJournal of Neurogastroenterology and Motility, 2015
Background/Aims Although adipocytes secrete inflammatory cytokines and adipokines, their role in reflux esophagitis is controversial. We investigated the association between visceral fat and inflammatory cytokines or adipokines in reflux esophagitis ...
S. Nam   +6 more
semanticscholar   +1 more source

Eosinophilic Esophagitis.

open access: yesNew England Journal of Medicine, 2021
Eosinophilic esophagitis (also known as EoE) is a disease characterized by the presence of a large number of a special type of white blood cell, the eosinophil, that can cause inflammation in the esophagus.
G. Furuta, D. Katzka
semanticscholar   +1 more source

Pathogenesis of Reflux Esophagitis

open access: yesGastroenterology, 1981
During the past decade considerable new information has accrued about reflux esphagitis and the physiology of esophageal motor function. Although numerous reports review the clinical, diagnostic, and therapeutic aspects of reflux esophagitis (1-6), few reports (7) focus primarily on the pathophysiology of esophagitis production. Our purpose here is to:
James F. Helm   +3 more
openaire   +3 more sources

Lymphocytic Esophagitis in Nonachalasia Primary Esophageal Motility Disorders: Improved Criteria, Prevalence, Strength of Association, and Natural History. [PDF]

open access: yes, 2016
Lymphocytic esophagitis (LE) is a histologic pattern with no established clinical correlates in the majority of patients. The goal of this study was to evaluate the association between nonachalasia primary esophageal motility disorders (PEMD) and LE ...
Brickley, Elizabeth B   +8 more
core   +1 more source

Clinical Outcome of Modified Laparoscopy-Assisted Proximal Gastrectomy Compared to Conventional Proximal Gastrectomy or Total Gastrectomy for Upper-Third Early Gastric Cancer with Special References to Postoperative Reflux Esophagitis

open access: yesJournal of Gastric Cancer, 2015
Purpose This study evaluated the functional and oncological outcomes of proximal gastrectomy (PG) in comparison with total gastrectomy (TG) for upper-third early gastric cancer (EGC).
Y. Huh   +9 more
semanticscholar   +1 more source

Management of Gastroesophageal Reflux Disease (GERD) [PDF]

open access: yes, 2001
Even though there are still no epidemiological data on the prevalence of Gastro Esophageal Reflux Disease (GERD) in Indonesia, data from The Division of Gastroenterology Department of Internal Medicine Cipto Mangunkusumo Hospital demonstrate signs of ...
Makmun, D. (Dadang)
core   +1 more source

Integrated Metabolic and Inflammatory Clustering Reveals Distinct Risk Profiles for Digestive Diseases

open access: yesAdvanced Science, EarlyView.
This study analyzes 398 432 participants, identifying four distinct metabolic‐inflammatory subtypes. These subtypes show a significant association with digestive disease risk. Cluster‐associated metabolite signatures partially explain this link. Machine learning models using these metabolites accurately predict risk for ten digestive diseases. Key risk
Zhenhe Jin   +10 more
wiley   +1 more source

Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan

open access: yesJournal of clinical biochemistry and nutrition, 2015
Proton pump inhibitors are the first-line treatment for reflux esophagitis. Because severe reflux esophagitis has very low prevalence in Japan, little is known about the effectiveness of proton pump inhibitors in these patients.
H. Mizuno   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy